StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Thursday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Down 8.8 % Shares of BTX opened at $1.76 on Thursday. The firm has a 50-day moving average price of $2.24 and a […]